Paper4863911
The specific inhibition of the DNA-directed RNA synthesis by rifamycin.
Hartmann G and 3 others. Biochim Biophys Acta, 1967. Cited by 481 papers, by iCite.
Cite this record
ConductScience Library. The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Papers, record 4863911. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4863911
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA | Major topic |
| RNA, Bacterial | Major topic |
| Rifampin | Major topic |
| Staphylococcus | Major topic |
| Carbon Isotopes | |
| DNA Nucleotidyltransferases | |
| Depression, Chemical | |
| Escherichia coli | |
| Nucleotides | |
| RNA Nucleotidyltransferases | |
| Templates, Genetic | |
| Thymus Gland | |
| Uracil |
Source PubMed
Cited by189
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 481 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42516079 | GapR stiffens AT-rich and overtwisted DNA leading to differential effects on transcription based on gene context. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42516079 | PubMed |
| 42427542 | Phosphoarginine modulates oligomerization and repressor activity of mycobacterial ClpC2. | bioRxiv | 2026 | https://conductscience.org/library/papers/42427542 | PubMed |
| 41729463 | Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging uses. | Pharmacol Rep | 2026 | https://conductscience.org/library/papers/41729463 | PubMed |
| 41104949 | Principles of bacteriostatic and bactericidal antibiotics at subinhibitory concentrations. | mBio | 2025 | https://conductscience.org/library/papers/41104949 | PubMed |
| 40757508 | Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40757508 | PubMed |
| 40728034 | Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40728034 | PubMed |
| 40552714 | Nonequilibrium polysome dynamics promote chromosome segregation and its coupling to cell growth in Escherichia coli. | Elife | 2025 | https://conductscience.org/library/papers/40552714 | PubMed |
| 40430474 | Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430474 | PubMed |
| 37403359 | Environmental conditions define the energetics of bacterial dormancy and its antibiotic susceptibility. | Biophys J | 2023 | https://conductscience.org/library/papers/37403359 | PubMed |
| 37397488 | Bifunctional antibiotic hybrids: A review of clinical candidates. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37397488 | PubMed |
| 37289062 | Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37289062 | PubMed |
| 37237771 | Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37237771 | PubMed |
| 36881456 | A novel proteinaceous molecule produced by Lysinibacillus sp. OF-1 depends on the Ami oligopeptide transporter to kill Streptococcus pneumoniae. | Microbiology (Reading) | 2023 | https://conductscience.org/library/papers/36881456 | PubMed |
| 36841858 | An Overview of Mycoviral Curing Strategies Used in Evaluating Fungal Host Fitness. | Mol Biotechnol | 2023 | https://conductscience.org/library/papers/36841858 | PubMed |
| 36761902 | Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: A comprehensive review. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/36761902 | PubMed |
| 36714853 | C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus. | PNAS Nexus | 2022 | https://conductscience.org/library/papers/36714853 | PubMed |
| 36584037 | High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia. | PLoS One | 2022 | https://conductscience.org/library/papers/36584037 | PubMed |
| 36339603 | Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36339603 | PubMed |
| 36290036 | Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36290036 | PubMed |
| 36228001 | A machine learning model trained on a high-throughput antibacterial screen increases the hit rate of drug discovery. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/36228001 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4863911
GET https://conductscience.org/api/papers/v1/4863911/cited_by?page=2